Atsushi Murakami

ORCID: 0000-0002-1972-0134 · 6 papers in corpus
case-report 2025
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.16253

Cesarean scar defect (CSD) is a long-term complication of cesarean section (CS). However, its risks for perimenopausal women remain unclear. We present a rare case of CSD involving hematometra in a perimenopausal woman, which led to emergen…

article 2022
Journal of gynecologic oncology ·doi:10.3802/jgo.2022.33.e34

Up to 1% of women with endometriosis develop endometriosis-associated neoplasms [1]. Most endometriosis-associated malignant tumors develop from the ovarian endometriomas, whereas those developing from extragonadal lesions are extremely rar…

review 2021
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox10020187

Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stres…

article 2021

Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stres…

review 2021
Japanese journal of radiology ·doi:10.1007/s11604-021-01096-7

Uterine sarcomas account for less than 1% of gynecological malignancies and 2-5% of all uterine malignancies. Such sarcomas mainly include leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS). Additionally, inflammatory myofibroblasti…

review 2017
Japanese journal of radiology ·doi:10.1007/s11604-017-0681-4

Müllerian duct anomalies (MDAs) are the result of incomplete development, vertical or lateral fusion, or absorption of the müllerian ducts. The range of anomalies includes uterovaginal agenesis or hypoplasia, unicornuate uterus, uterus dide…